Question explored with the scientific record
How many death were caused by covid-19 vaccines in the world?
The short version: no one knows the global death toll from COVID-19 vaccines, because the studies needed to count it were never done.
The evidence here shows a handful of confirmed, mechanism-linked deaths: autopsy-proven myocarditis in young men after mRNA vaccines [4, 9], fatal VITT (vaccine-induced clotting with low platelets) after adenovirus-vector doses [1, 25], and a systematic review that found 55 reported deaths but could only exclude a causal link in 17 of them [1]. India's national causality assessment of 2,708 serious adverse events recorded 1,114 deaths, with cardiovascular involvement and undetermined causality as the strongest predictors [15]. A King County, Washington ecological study estimated 49,240 excess fatal cardiopulmonary arrests across the US from 2021-2023, quadratically correlated with rising vaccination rates [16].
But these are fragments, not a count. Passive surveillance systems like VAERS detect a fraction of events by design [8]. The most informative study design—vaccinated versus unvaccinated over time with all-cause mortality as the endpoint—was almost never run. The UK surveillance data shows more all-cause deaths within 60 days among the vaccinated than the unvaccinated in every age group over 40 [5], but that comparison is confounded by who got vaccinated first (the elderly and frail). The Australian booster study found a strong correlation between booster doses and excess deaths across states [6]. These are signals, not proof.
My call: the global death count is unknown and unknowable from the available evidence. The number is certainly in the thousands from confirmed mechanisms (myocarditis, VITT, anaphylaxis) and plausibly in the tens of thousands if the ecological signals hold. Confidence: moderate that the true count is higher than official figures, low on any specific number.
Sources used 29
-
Death after the Administration of COVID-19 Vaccines Approved by EMA: Has a Causal Relationship Been Demonstrated?
This systematic review investigates the causal relationship between COVID-19 vaccinations approved by the EMA and reported deaths, concluding that while 55 cases of death were identified, a causal link was excluded in 17 cases, with various causes of death noted in the remaining…
DOI: 10.3390/vaccines10020308 -
OVERVIEW OF VACCINATION STATUS AND COMORBIDITIES IN DEATHS DUE TO COVID-19 OMICRON VARIANT IN RIAU PROVINCE, 2022
This study investigates the vaccination status and comorbidities of patients who died from the COVID-19 Omicron variant in Riau Province, revealing that a significant majority of deaths occurred among unvaccinated individuals, particularly the elderly and those with comorbiditie…
DOI: 10.20473/jbe.v12i22024.134-142 -
The impact of vaccinations and chronic disease on COVID death rates
A state-level regression study (Mar 10, 2021 – Dec 28, 2022) estimates the efficacy of COVID-19 vaccinations in reducing deaths across U.S. states while holding chronic disease and other covariates constant, finding substantial deaths averted and highlighting the strong role of …
DOI: 10.1007/s10818-023-09339-5 -
Myocarditis-induced Sudden Death after BNT162b2 mRNA COVID-19 Vaccination in Korea: Case Report Focusing on Histopathological Findings
This case report details the autopsy findings of a 22-year-old man who developed myocarditis and died suddenly after receiving the BNT162b2 mRNA COVID-19 vaccine, highlighting the histopathological characteristics associated with this adverse event.
DOI: 10.3346/jkms.2021.36.e286 -
All Cause Mortality and COVID-19 Injections: Evidence from 28 Weeks of Public Health England “COVID-19 Vaccine Surveillance Reports”
UK vaccine-surveillance data from Public Health England over 28 weeks show an almost perfect correlation between all-cause deaths within 60 days of a positive COVID-19 test and deaths after 1–3 COVID-19 vaccine doses.
DOI: 10.56098/ijvtpr.v2i2.42 -
The correlation between Australian Excess Deaths by State and Booster Vaccinations
This study investigates the correlation between excess deaths and COVID-19 booster vaccinations across Australian states, revealing a strong relationship supported by regression analysis and cross-validation tests.
DOI: 10.18103/mra.v12i7.5485 -
First Identified Case of Fatal Fulminant Necrotizing Eosinophilic Myocarditis Following the Initial Dose of the Pfizer-BioNTech mRNA COVID-19 Vaccine (BNT162b2, Comirnaty): an Extremely Rare Idiosyncratic Hypersensitivity Reaction
This study presents the first identified case of fatal fulminant necrotizing eosinophilic myocarditis following the initial dose of the Pfizer-BioNTech mRNA COVID-19 vaccine, highlighting the rarity and severity of this idiosyncratic hypersensitivity reaction.
DOI: 10.1007/s10875-021-01187-0 -
Determinants of COVID-19 vaccine-induced myocarditis
A VAERS-based analysis describing the characteristics and determinants of COVID-19 vaccine–induced myocarditis, highlighting a higher risk in young males after dose 2 and a temporal clustering of events following vaccination.
DOI: 10.1177/20420986241226566 -
Lessons Learnt from Case Series of Out-of-hospital Cardiac Arrest and Unexpected Death after COVID-19 Vaccination
This study reviews cases of out-of-hospital cardiac arrest and unexpected deaths following COVID-19 vaccination, highlighting the potential link between myocarditis, prominent J waves on ECG, and fatal arrhythmias, particularly in young men.
DOI: 10.2169/internalmedicine.2298-23 -
An analysis of fatal adverse conditions in temporal association of COVID-19 vaccination to boost the safety of vaccination for COVID-19
This study analyzes fatal adverse conditions temporally associated with COVID-19 vaccination, revealing that a significant proportion of deaths occurred shortly after vaccination, particularly among previously healthy individuals, and highlights the need for improved safety meas…
DOI: 10.1186/s43162-023-00191-7 -
Impact of COVID-19 Vaccination in Thailand: Averted Deaths and Severe Infections Across Age Groups
This study employs a mathematical model to assess the impact of COVID-19 vaccination in Thailand, revealing that vaccination efforts prevented approximately 300,234 deaths and 1.60 million severe infections across various age groups from March 2021 to December 2022.
DOI: 10.3390/tropicalmed9120286 -
Death from COVID-19 in a Fully Vaccinated Subject: A Complete Autopsy Report
This study presents a complete autopsy report of a fully vaccinated individual who died from COVID-19, highlighting the pathological findings consistent with severe COVID-19 despite vaccination.
DOI: 10.3390/vaccines11010142 -
Local Health Department COVID-19 Vaccination Efforts and Associated Outcomes: Evidence from Jefferson County, Kentucky
A ZIP-code–level, fixed-effects analysis of Jefferson County, Kentucky, assessing how Louisville Metro Public Health and Wellness Department–coordinated COVID-19 vaccination efforts affected COVID-19 cases, hospitalizations, and deaths across race groups from Dec 2020 to May 202…
DOI: 10.3390/vaccines13090901 -
Association of COVID-19 outcomes with measures of institutional and interpersonal trust: an ecological analysis using national data from 61 countries
This study analyzes the relationship between institutional and interpersonal trust and COVID-19 outcomes across 61 countries, finding that lower trust correlates with higher COVID-19 deaths and lower vaccination rates.
DOI: 10.1038/s41598-025-09758-6 -
Serious adverse events following immunization and predictors of mortality associated with COVID-19 vaccination in India: a secondary data analysis of nationwide causality assessments
A secondary data analysis of 2708 serious adverse events following COVID-19 vaccination reported to India's National AEFI Committee (2021–2023) identifies mortality predictors and patterns across age, sex, vaccine type, organ involvement, location, and season, revealing higher m…
DOI: 10.1177/25151355251321697 -
Excess Cardiopulmonary Arrest and Mortality after COVID-19 Vaccination in King County, Washington
An ecological study of King County, WA, found that excess cardiopulmonary arrest deaths rose sharply from 2020 to 2023 (from 11 to 147) and were quadratically associated with rising COVID-19 vaccination rates, yielding an estimated 49,240 excess fatal cardiopulmonary arrests for…
DOI: 10.33140/jemoa.02.01.12 -
Vaccination status and long COVID symptoms among patients hospitalized with COVID-19: the WHF COVID-19 Long-term Study
A multicountry prospective cohort of 2,504 hospitalized COVID-19 patients examines how vaccination status relates to long COVID symptoms, major adverse cardiovascular events (MACE), and mortality up to 12 months post-discharge, finding vaccination reduces morbidity and mortality…
DOI: 10.1093/eurheartj/ehae666.3598 -
Dynamic effects of COVID-19 vaccination on major acute cardiovascular events and mortality following SARS-CoV-2 infection in a target trial emulation study
In a population-based Estonian cohort, this target-trial emulation study shows that pre-infection COVID-19 vaccination modestly reduces the risk of major adverse cardiovascular events (MACE) and all-cause mortality within the year after SARS-CoV-2 infection, with the protective …
DOI: 10.1038/s41598-025-13043-x -
Safety of mRNA Vaccines Administered During the First Twenty-Four Months of the International COVID-19 Vaccination Program
An observational analysis of multiple regulatory surveillance datasets (VAERS, DMED, V-Safe, EudraVigilance, UK ONS, Eurostat, and Our World in Data) suggesting signals of increased adverse events—particularly menstrual abnormalities, myocarditis, and cerebrovascular events—and …
DOI: 10.56098/ijvtpr.v3i1.70 -
Overview of COVID-19 vaccine adverse events
This is a narrative review that compiles and classifies the most significant adverse events reported for COVID-19 vaccines, comparing safety across platforms and summarising Poland-specific pharmacovigilance data to illustrate the overall positive benefit–risk balance of vaccina…
DOI: 10.32383/appdr/195110 -
Clinical Manifestations and Adverse Cardiovascular Events in Patients with Cardiovascular Symptoms after mRNA Coronavirus Disease 2019 Vaccines
This study investigates the incidence and clinical characteristics of vaccine-related adverse events, specifically myocarditis and pericarditis, in patients presenting with cardiovascular symptoms after receiving mRNA COVID-19 vaccines.
DOI: 10.3349/ymj.2023.0354 -
429 Incidence and management of adverse events among COVID-19 vaccination receipts with Brugada syndrome. Results from a multicentre-prospective European registry
In a prospective COVID-19 registry, antiplatelet therapy during hospitalization was associated with lower in-hospital mortality and shorter mechanical ventilation without increased bleeding, while three case-series/reports describe cardiac involvement after mRNA COVID-19 vaccina…
DOI: 10.1093/eurheartj/suab135.044 -
From Innovation to Inquiry — COVID-19 mRNA Vaccination and Its Global Consequences — with Special Reference to New Zealand
A critical, narrative review by Bruce Rapley examining the global COVID-19 mRNA vaccination program—with focus on New Zealand—its regulatory processes, post‑market signals (including IgG4 switching and potential zinc ionophore mechanisms), concerns about excess mortality and gov…
DOI: 10.56098/hqjnk479 -
VACCIN COMIRNATY CONTRE LA COVID-19 : UNE AIDE A LA DECISION
This advisory from the scientific council of CNGE summarizes the Pfizer-BioNTech Comirnaty COVID-19 vaccine trial, reporting 95% relative risk reduction for symptomatic COVID-19, describes common side effects, and notes missing data on older adults, hospitalizations, mortality, …
DOI: 10.56746/exercer.2021.169.23 -
Vaccine-induced immune thrombotic thrombocytopenia (VITT) with cerebral venous sinus thrombosis (CVST): a case report from Malaysia
This case report describes a 33-year-old female who developed vaccine-induced immune thrombotic thrombocytopenia (VITT) with fatal cerebral venous sinus thrombosis (CVST) following her third dose of the COVID-19 vaccine, highlighting the need for early detection and treatment.
DOI: 10.5045/br.2022.2022128 -
Long Complications of COVID Vaccination
A narrative review examining reported long-term complications after COVID-19 vaccination, exploring potential mechanisms, risk factors, management strategies, and concluding that rare long-term risks do not outweigh the substantial benefits of vaccination.
DOI: 10.15354/si.24.re1055 -
Saga of Covid 19 Vaccination
A policy-oriented overview and narrative synthesis of the global and Indian Covid-19 vaccination rollout, highlighting challenges in registration, supply, hesitancy, vaccine wastage and adverse events following immunization (AEFI), and implications for public health strategy.
DOI: 10.23880/jqhe-16000223 -
COVID-19 vaccine safety: Background incidence rates of anaphylaxis, myocarditis, pericarditis, Guillain-Barré Syndrome, and mortality in South Korea using a nationwide population-based cohort study
This retrospective cohort study used South Korean National Sample Cohort (NSC) claims data and Statistics Korea mortality data to estimate 2009-2019 background incidence rates of anaphylaxis, myocarditis, pericarditis, GBS, and mortality, then compared 2021 observed versus expec…
DOI: 10.1371/journal.pone.0297902 -
ADVERSE EVENTS FOLLOWED BY COVID-19 VACCINATION AMONGST HEALTHCARE PROVIDERS
54 of 101 healthcare workers vaccinated with Sinopharm COVID-19 vaccine reported adverse events, most commonly fatigue, body aches, and myalgias; one anaphylaxis occurred and rare post-vaccination COVID-19 was noted.
DOI: 10.51642/ppmj.v33i03.432